Medical Devices Startups

PSYONIC develops advanced prosthetic hands with sensory feedback capabilities designed to be affordable and accessible globally, particularly for people with limb differences in underresourced regions. The company combines engineering expertise with clinical partnerships to advance bionic technology at scale.

1 investor

Pulmatrix develops inhaled dry-powder therapies using its proprietary iSPERSE technology, which uses small, dense, dispersible particles to deliver respiratory and non-respiratory drugs via the respiratory system. The company pursues its own drug pipeline and partnerships with pharmaceutical companies across drug classes.

1 investor

Pulmotect develops immunomodulatory inhaled therapies designed to activate the lungs' innate immune system for preventing and treating respiratory complications in immunosuppressed patients and other high-risk populations. The company is advancing PUL-042, a patent-protected therapy being evaluated in clinical trials.

1 investor

Pumpinheart, a spinout from the Royal College of Surgeons in Ireland, is developing an implantable diastolic pump to treat advanced heart failure with preserved ejection fraction (HFpEF). Its device reduces left atrial pressure and is delivered via transcatheter implantation for Stage C and D HFpEF patients.

1 investor

Pumpkin VR develops AI-driven guide systems and extended reality simulation training solutions for museums, defense operations, medical education, and industrial safety across government facilities, hospitals, and enterprises. The company offers six solution categories including AI tour narration, XR/VR/MR immersive training, and AI eldercare interaction systems, deployable on cloud, private cloud, on-premise, or fully offline infrastructure.

1 investor

Pure MHC discovers HLA Class I and Class II peptide targets for immunotherapies targeting cancer, infectious disease, and autoimmune diseases using the sHLA platform technology.

1 investor

Purgo Scientific develops localized drug delivery medical devices designed to deliver therapeutics to specific anatomical sites. The company serves clinical markets including orthopedic trauma and veterinary medicine, with commercialized veterinary products and human clinical development underway.

1 investor

PurpleLab transforms real-world health data into actionable insights for healthcare and life sciences organizations. The company serves pharmaceutical, biotech, and provider organizations seeking to translate data into measurable clinical and business outcomes.

1 investor

PVRMED develops the PVR System, a medical therapy aimed at treating diabetic foot conditions including diabetic foot ulcers, diabetic neuropathy (DSPN), and peripheral artery disease. It targets clinicians such as diabetologists, vascular surgeons, wound care specialists, and podiatrists, and has been used in clinical trials across four countries.

1 investor

PyrAmes develops a noninvasive, continuous wireless blood pressure monitoring platform (Boppli) for neonatal and pediatric patients, as well as adults, addressing the need for continuous BP monitoring without invasive arterial lines. The company operates in the digital health and medical device space.

1 investor

Pyrojas develops whole-cell cancer vaccines engineered from patients' own tumors to activate T cell responses against multiple antigens. The company focuses on precision immunotherapy for cancer treatment.

1 investor

Q-Sera is a biotech company backed by Australian investors Uniseed and Brandon BioCatalyst, emerging from University of Queensland commercialisation efforts.

1 investor

QCDx develops liquid biopsy technologies using live 3D imaging to detect and profile circulating tumor cells for cancer diagnosis and drug development. The RareScope platform enables oncologists to optimize treatment strategies and therapeutic agents through single-cell phenotypic analysis of rare cancer cells in early-stage and advanced disease.

1 investor

QDI Systems develops quantum dot-based imaging products for medical X-ray, mammography, and specialized imaging applications. The company manufactures proprietary quantum dot films for use in X-ray detectors and near-infrared imaging systems.

1 investor

Qlaris Bio is a clinical-stage biotechnology company developing therapies for ophthalmology conditions. Its lead candidate, QLS-111, is a topical eye-drop treatment for glaucoma that lowers intraocular pressure by targeting episcleral venous pressure.

1 investor

QMB is a vertical SaaS platform combining an AI engine with embedded regulatory experts to help MedTech companies plan product development and prepare FDA submissions. It serves MedTech founders and RA/QA teams working through regulatory strategy, documentation, and compliance in the medical device industry.

1 investor

Qnomx provides AI-powered genomic analysis and interpretation for precision oncology, enabling oncologists to deliver individualized cancer treatment decisions based on clinical-grade insights.

1 investor

Qnovia develops a portable, pre-filled vibrating mesh nebulizer (RespiRx) that delivers nicotine via ultrasonic nebulization without combustion, paired with a cloud-connected AI platform (Neblit) providing real-time behavioral support for smoking cessation. The company targets patients seeking nicotine replacement therapy in the pulmonary drug delivery and digital health space.

1 investor

QNTM Labs is a GMP-certified contract laboratory providing quality control testing and chemical analysis services for pharmaceutical companies, with particular expertise in small molecule drugs. The company offers outsourced QC activities, analytical method development, stability studies, and trace element analysis to help pharmaceutical manufacturers meet regulatory compliance and quality standards.

1 investor

Qoly Corporation develops, manufactures, and sells microsurgery-assist robots and related products, using robotics to help surgeons perform precise and safe microsurgery for functional disorders. The Japan-based company, spun out of Sony, targets surgical care providers to expand access to advanced microsurgical treatment.

1 investor

Qrem develops a lab-in-a-box medical device that produces autologous cytokine-rich serum (SARC) from a patient's own blood for regenerative medicine treatment of soft and hard tissue damage. The device enables healthcare practitioners to prepare and administer the therapy directly in their clinic without specialized infrastructure.

1 investor

Develops lateral flow assay (LFA) diagnostic test kits for urine-based and blood-based testing, offering a range of products across various test panels. The kits include the test kit, manual, and desiccant.

1 investor

QSM Diagnostics develops bacterial infection testing for pets using Quorum Sensing Technology, offered as mail-in kits and in-clinic instruments. It serves veterinary clinics and pet owners with rapid diagnostics for issues such as ear infections, aiming to speed treatment decisions and reduce antimicrobial resistance.

1 investor

QTSense develops quantum sensors operating at the nanoscale to detect subtle biological signals for research and diagnostic applications. The company serves academic and pharmaceutical researchers seeking earlier disease detection and improved treatment development.

1 investor